AU1252902A - Method of measuring platelet activation - Google Patents

Method of measuring platelet activation

Info

Publication number
AU1252902A
AU1252902A AU1252902A AU1252902A AU1252902A AU 1252902 A AU1252902 A AU 1252902A AU 1252902 A AU1252902 A AU 1252902A AU 1252902 A AU1252902 A AU 1252902A AU 1252902 A AU1252902 A AU 1252902A
Authority
AU
Australia
Prior art keywords
platelet
platelet activation
measuring platelet
component
activation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
AU1252902A
Other languages
English (en)
Inventor
Marion Glenys Macey
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Barts Health NHS Trust
Original Assignee
Barts Health NHS Trust
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Barts Health NHS Trust filed Critical Barts Health NHS Trust
Publication of AU1252902A publication Critical patent/AU1252902A/xx
Pending legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5094—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for blood cell populations
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/86—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood coagulating time or factors, or their receptors
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/10—Composition for standardization, calibration, simulation, stabilization, preparation or preservation; processes of use in preparation for chemical testing
    • Y10T436/108331—Preservative, buffer, anticoagulant or diluent
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/25—Chemistry: analytical and immunological testing including sample preparation
    • Y10T436/2525—Stabilizing or preserving

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Cell Biology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Pathology (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Ecology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
  • Investigating Or Analysing Materials By Optical Means (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU1252902A 2000-11-08 2001-11-08 Method of measuring platelet activation Pending AU1252902A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0027309.4A GB0027309D0 (en) 2000-11-08 2000-11-08 Method of measuring measuring platlet activation
PCT/GB2001/004946 WO2002039124A1 (en) 2000-11-08 2001-11-08 Method of measuring platelet activation

Publications (1)

Publication Number Publication Date
AU1252902A true AU1252902A (en) 2002-05-21

Family

ID=9902807

Family Applications (2)

Application Number Title Priority Date Filing Date
AU1252902A Pending AU1252902A (en) 2000-11-08 2001-11-08 Method of measuring platelet activation
AU2002212529A Ceased AU2002212529B2 (en) 2000-11-08 2001-11-08 Method of measuring platelet activation

Family Applications After (1)

Application Number Title Priority Date Filing Date
AU2002212529A Ceased AU2002212529B2 (en) 2000-11-08 2001-11-08 Method of measuring platelet activation

Country Status (9)

Country Link
US (1) US7011938B2 (cg-RX-API-DMAC10.html)
EP (1) EP1332373B1 (cg-RX-API-DMAC10.html)
JP (1) JP2004513369A (cg-RX-API-DMAC10.html)
AT (1) ATE522808T1 (cg-RX-API-DMAC10.html)
AU (2) AU1252902A (cg-RX-API-DMAC10.html)
CA (1) CA2428224C (cg-RX-API-DMAC10.html)
ES (1) ES2372810T3 (cg-RX-API-DMAC10.html)
GB (1) GB0027309D0 (cg-RX-API-DMAC10.html)
WO (1) WO2002039124A1 (cg-RX-API-DMAC10.html)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2392724A (en) * 2002-09-06 2004-03-10 Ian Stoakes Methods of and apparatus for blood analysis
EP1814563A4 (en) * 2004-07-26 2008-04-16 Bayer Healthcare Llc PLATTOCK ACTIVATING MARKERS AS PREDICATORS OF ILLNESSES AND THE RESPONSE TO TREATMENTS AND MONITORING THERAPEUTIC PROGRESS
US7811549B2 (en) 2006-07-05 2010-10-12 Adenobio N.V. Methods, compositions, unit dosage forms, and kits for pharmacologic stress testing with reduced side effects
US8021854B2 (en) * 2007-10-05 2011-09-20 Attila Mady Method of treating vascular disease
US8835104B2 (en) * 2007-12-20 2014-09-16 Fenwal, Inc. Medium and methods for the storage of platelets
US20090185973A1 (en) * 2008-01-22 2009-07-23 Adenobio N.V. Methods, compositions, unit dosage forms, and kits for pharmacologic stress testing with reduced side effects
US10575515B2 (en) 2010-05-04 2020-03-03 The General Hospital Corporation Methods and compositions for preserving tissues and organs
WO2012139017A1 (en) 2011-04-07 2012-10-11 Fenwal, Inc. Automated methods and systems for providing platelet concentrates with reduced residual plasma volumes and storage media for such platelet concentrates
ES2968371T3 (es) 2013-10-10 2024-05-09 Eastern Virginia Medical School Derivados de 4-((2-hidroxi-3-metoxibencil)amino) bencenosulfonamida como inhibidores de la 12-lipoxigenasa
JP6687601B2 (ja) * 2014-08-07 2020-04-22 ザ ジェネラル ホスピタル コーポレイション 全血サンプルの安定化
US10908171B2 (en) 2016-07-12 2021-02-02 EMULATE, Inc. Additive channels

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH08220094A (ja) * 1995-02-08 1996-08-30 Dai Ichi Pure Chem Co Ltd 血漿中ｇｍｐ−１４０の測定法
FR2731277A1 (fr) * 1995-03-02 1996-09-06 Benveniste Jacques Procedes et appareil pour faciliter la purification, le comptage et la mesure de l'activation des leucocytes sanguins
US5817519A (en) * 1995-12-28 1998-10-06 Bayer Corporation Automated method and device for identifying and quantifying platelets and for determining platelet activation state using whole blood samples
US6309888B1 (en) * 1998-09-04 2001-10-30 Leuven Research & Development Vzw Detection and determination of the stages of coronary artery disease

Also Published As

Publication number Publication date
US7011938B2 (en) 2006-03-14
EP1332373A1 (en) 2003-08-06
US20040038997A1 (en) 2004-02-26
ES2372810T3 (es) 2012-01-26
AU2002212529B2 (en) 2006-08-10
EP1332373B1 (en) 2011-08-31
CA2428224A1 (en) 2002-05-16
JP2004513369A (ja) 2004-04-30
GB0027309D0 (en) 2000-12-27
CA2428224C (en) 2010-04-27
WO2002039124A1 (en) 2002-05-16
ATE522808T1 (de) 2011-09-15

Similar Documents

Publication Publication Date Title
EP1212613A4 (en) HEMATOLOGICAL CONTROL AND SYSTEM FOR HEMATOLOGIC MUCH PARAMETER MEASUREMENTS
FI905725L (fi) Reagenssi ja sitä käyttävä menetelmä vähintään yhden leukosyyttialapopulaation määrittämiseksi kokoverestä automaattisella virtaussolulaskennalla
GB0027309D0 (en) Method of measuring measuring platlet activation
FI915150A7 (fi) Menetelmät, reagenssit ja testikäyttöpakkaukset biologisten yksiköiden alapopulaatioiden määrittämiseksi
BR0014801A (pt) Sistemas de processamento de sangue que monitoram densidades óticas
WO2002046746A3 (en) Method for detection of vitamin d metabolites
BR9507690A (pt) Detecção de reticulócitos
DE69011198D1 (de) Verfahren zur Differenzierung von Leukozyten mit Hilfe eines Durchflusszellmessgerätes.
WO2002027326A3 (en) Method and kit for the transderaml determination of analyte concentration in blood
DE69917051D1 (de) "flow-zytometrischer" vollblut- dendritzelle- immunfunctiontest
DE69920078D1 (de) Vorrichtung und Verfahren zur Bestimmung der Bohrmethode, um Formationsbewertungsmessungen zu optimieren
FI901144A7 (fi) Kertakäyttöinen mittapuikko vaginan pH:n tai muun vastaavan suureen mittaamiseksi
WO2000023614A8 (en) Method for monitoring proteasome inhibitor drug action
IL95485A0 (en) Acridine derivatives,reagent compositions containing them and their use in the quantitative determination of reticulocytes in whole blood
EP0814336A3 (en) Reagents and methods for releasing and measuring lead from biological matrices
EP0853761A4 (en) STANDARD FOR BLOOD CONTROL
BR9406223A (pt) Método para determinar em uma amostra a atividade funcional de um componente da coagulação sanguinea método para diagnosticar um disturbio da coagulação/anticoagulação sanguinea preparado de anticorpo linhagem celular uso de fator v subunidades ou fragmentos do mesmo tendo atividade anticoagulante na forma de cofator par apc prepraro de plasma embalado plasma deficiente em atividade anticoagulante de fator v como cofator para apc uso do preparado de anticorpo preparado de proteina s preparado de
DE3852439D1 (de) Reagenz zur Retikulozytenzählung mittels Durchfluss-zytometrie.
AU3259999A (en) Method of measuring erythrocyte sedimentation rate (esr) or plasma fibrinogen ofa blood sample
AU4462289A (en) Aqueous suspension for diagnostic tests
DE59914955D1 (de) Multiküvettenrotor
DE68917387D1 (de) Dioxetane zur verwendung bei immuntests.
WO2002012885A3 (de) Einfache methode zum drug monitoring von gpiib/iiia-rezeptor-antagonisten
ES2136272T3 (es) Procedimientos de ensayo y dispositivos para los mismos.
MXPA03012062A (es) Metodo para realizar el analisis de conectividad sobre base-objeto en volumenes tridimensionales de datos sismicos.